CIPO Patents = 3

Forward Citations = 12

Loading Chart...

4 inventors (with patents filed for the assignee):

Kurt B Osther (7 out of 20 patents)

Gottfried H Kellermann (3 out of 3 patents)

Louis M Dyll (1 out of 2 patents)

4. Chung-Ho Hung (1 out of 4 patents)

7 patents: Sort by Forward Citations

1. 5830476 - Active induction or passive immunization of anti-Gp48 antibodies and (1998-11-03),

2. 5658569 - Anti-HIV-1 neutralizing antibodies (1997-08-19),

3. 5529776 - Anti-HIV-1 neutralizing antibodies (1996-06-25),

4. 5516895 - Antibodies specific towards gp 48 (1996-05-14),

5. 5286852 - Antibodies specific towards HIV-1 gp 48 (1994-02-15),

6. 5264342 - Method for determining the sensitivity and/or specificity of an assay (1993-11-23),

7. 5093230 - Method for rapid and sensitive detection of IgM retroviral antibodies (1992-03-03),

Company Overview

Verigen, Inc. is a biotechnology company focused on developing groundbreaking technologies for personalized cell therapies. With a team of experts in stem cell research and regenerative medicine, Verigen is dedicated to revolutionizing the field of cell therapy to help patients with various medical conditions. Their cutting-edge solutions aim to optimize the production of personalized cell therapies, making them more efficient and accessible to patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#40 in Framingham, MA

#2,306 in Massachusetts

#39,929 in US

Framingham, MA, United States of America

Verigen, Inc.

Forward Citations = 12

4 inventors:

Kurt B Osther (7 out of 20 patents)

Gottfried H Kellermann (3 out of 3 patents)

Louis M Dyll (1 out of 2 patents)

4. Chung-Ho Hung (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Verigen, Inc.. Retrieved from https://idiyas.com/company/verigen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]